ReviewFrontiers in immunology2021

Unexpected Favorable Outcome to PD-1 Antibody Plus Lenvatinib in a Patient With Recurrent Intestinal Follicular Dendritic Cell Sarcoma: A Case Report and Literature Review.

Yanna Lei et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.